NL-OMON47645已完成不适用
BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial - BioXmark, rectal feasibility trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* patients with histological or cytological proven rectal cancer, treated with long course external beam radiotherapy
- •* Age 18 year or older
- •* have given written informed consent
排除标准
- •* iodine allergy
研究者
相似试验
尚未招募
2 期
ow dose X-ray therapy for COVID-19CTRI/2021/04/033158Harshamitra Superspecialty Cancer Centre and Research Institute
暂停
Unknown
Radiobiological characterisation and therapy monitoring of oligo- compared to polymetastatic breast cancerC50Malignant neoplasm of breastDRKS00031591Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf50
尚未招募
2 期
Heads Up: A Phase II trial of a radiotherapy-based intervention for depression and malnutrition in Head and Neck cancer patients.Malnutrition and depression in Head and Neck Cancer during radiotherapyCancer - Head and neckACTRN12609000384257Calvary Mater Newcastle70
招募中
不适用
Stereotactic Body Radiotherapy for the Management of Prostate Cancer Local RecurrencesC61Malignant neoplasm of prostateDRKS00030837Europäisches Radiochirurgie Centrum München50
招募中
2 期
Cyberknife auto-planning high-dose intensity SBRT trialnon-small cell lung cancerJPRN-jRCTs032230014Onishi Hiroshi80